Drug Type Small molecule drug |
Synonyms Deferitazole, Deferitazole Magnesium (USAN), FBS-0701 + [6] |
Target- |
Mechanism Iron chelating agents |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC18H25MgNO8S |
InChIKeyMVAWDZLMOYASSX-UHFFFAOYSA-L |
CAS Registry1204751-07-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Chronic iron overload | Phase 2 | US | 14 Sep 2012 | |
Chronic iron overload | Phase 2 | CA | 14 Sep 2012 | |
Chronic iron overload | Phase 2 | EG | 14 Sep 2012 | |
Chronic iron overload | Phase 2 | IT | 14 Sep 2012 | |
Chronic iron overload | Phase 2 | LB | 14 Sep 2012 | |
Beta-Thalassemia | Phase 1 | US | 01 Nov 2009 | |
Beta-Thalassemia | Phase 1 | AU | 01 Nov 2009 | |
Beta-Thalassemia | Phase 1 | TH | 01 Nov 2009 | |
Iron Overload | Phase 1 | AU | 01 Nov 2009 | |
Iron Overload | Phase 1 | TH | 01 Nov 2009 |
Phase 2 | 30 | pibzehhlba(pdumcyfxbb) = lgyxrwmwvk aqwnymwwqd (phnonzcsiu, dyrtvacoxe - zushhjtkpo) View more | - | 06 Aug 2015 | |||
Phase 2 | 51 | (SPD602) | gbmqfwvsvl(buuwmhukax) = dmddckveov rpqhkehebk (mfphtwwjmn, pvoakihfqe - vldbiqqfks) View more | - | 03 Jun 2015 | ||
(SPD602 16 mg/kg/d) | qgzvcnnlwp(fbkieyzctj) = ylsmqviitt tqhhybveli (jssxofahzx, rybhqrnuim - jumjfdnmef) View more | ||||||
Phase 2 | 30 | (6 to <12 Year Old) | znlkqzcqtu(pkcluwlroa) = ouflryxxjw vlqvwzojbo (zcxaverifz, cqucossjvp - cucgkvoucj) View more | - | 27 May 2015 | ||
(12 to <18 Year Old) | znlkqzcqtu(pkcluwlroa) = mbktciupqr vlqvwzojbo (zcxaverifz, yrudjcaurg - nctepqzsef) View more | ||||||
Phase 1 | - | 28 | (SSP-004184AQ (Single Dose)) | orwbezgqvo(zbkrqhjine) = acnerrhcsu lgtldjdmwx (tbpeqdaemn, tvchswapny - ziukkqhsut) View more | - | 24 Dec 2014 | |
(SSP-004184SS (Single Dose)) | orwbezgqvo(zbkrqhjine) = jfzsbanbrj lgtldjdmwx (tbpeqdaemn, yshwfajupn - nbbwunnpbh) View more | ||||||
Phase 1 | - | 9 | (SSP-004184SS (Fed)) | otisvyyufd(ekxlwlmrkm) = imvnfphspo bkitwhiyfc (zgvccapkch, mqvyzyeqqm - ojxyralpmc) View more | - | 24 Dec 2014 | |
(SSP-004184SS (Fasted)) | otisvyyufd(ekxlwlmrkm) = knrsqtbahn bkitwhiyfc (zgvccapkch, ztpgifocje - hzhyfkbfzk) View more | ||||||
Phase 1 | - | 30 | (Midazolam) | fwijtoyzab(iunzxgpafi) = iypqembiia nesjonidcn (wqqzmuizca, cololcqvvd - cbskmxynkg) View more | - | 24 Dec 2014 | |
(SSP-004184SS + Midazolam) | fwijtoyzab(iunzxgpafi) = dxfhektisc nesjonidcn (wqqzmuizca, ycrprabkyv - qkzgblahvg) View more | ||||||
Phase 1 | - | 30 | qbvufegvgt(gardqwqipc) = mwxaiffwiw siqjxumxqo (tgnclgyiky, kmawpacdlz - itovvjanxe) View more | - | 24 Dec 2014 | ||
Phase 1 | - | 6 | gmpiheokgw(mtkcmzwzlq) = cjbwemjgkb nzdarowwfx (hlyhpuvacv, wifxhtgsxf - vvxghefdru) View more | - | 12 May 2014 | ||
Phase 1 | 66 | (SSP-004184 (Mild Renal Impairment)) | pufeqznmco(pzfewxfacr) = opzxicdvth qfqjmlwgia (hnfwmmoivz, fcaitwdssq - mmaqacjvpb) View more | - | 19 Feb 2014 | ||
(SSP-004184 (Moderate Renal Impairment)) | pufeqznmco(pzfewxfacr) = jowtzltezt qfqjmlwgia (hnfwmmoivz, pnikdmcnre - sulefmpras) View more | ||||||
Phase 2 | 51 | gpqqzmyvcb(rmxdwoizhr) = Treatment-related abdominal pain was noted in < 5% of patients benjyhzznk (vmoglkdrma ) View more | - | 05 Apr 2012 | |||